Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study

被引:247
|
作者
van Haren, Neeltje E. M.
Pol, Hilleke E. Hulshoff
Schnack, Hugo G.
Cahn, Wiepke
Mandl, Rene C. W.
Collins, D. Louis
Evans, Alan C.
Kahn, Rene S.
机构
[1] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 CX Utrecht, Netherlands
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
关键词
schizophrenia; MRI; follow-up; voxel-based morphometry; frontal lobe; antipsychotic medication;
D O I
10.1038/sj.npp.1301347
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent volumetric magnetic resonance imaging ( MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
引用
收藏
页码:2057 / 2066
页数:10
相关论文
共 50 条
  • [1] Focal Gray Matter Changes in Schizophrenia across the Course of the Illness: A 5-Year Follow-Up Study
    Neeltje E M van Haren
    Hilleke E Hulshoff Pol
    Hugo G Schnack
    Wiepke Cahn
    René C W Mandl
    D Louis Collins
    Alan C Evans
    René S Kahn
    Neuropsychopharmacology, 2007, 32 : 2057 - 2066
  • [2] Gray matter changes in schizophrenia across the course of the illness: A five-year study
    Van Haren, NEM
    Hulshoff Pol, HE
    Schnack, HG
    Cahn, W
    Brans, R
    Laponder, AJ
    Kahn, RS
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 23 - 23
  • [3] Prospective follow-up study of 5-year course and outcome in schizophrenia
    Bailer, J
    Rey, ER
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2001, 30 (04): : 229 - 240
  • [4] NEUROCOGNITIVE DEFICIT CHANGES IN RELATION TO THE COURSE OF SCHIZOPHRENIA AND SCHIZOPHRENIA SPECTRUM DISORDERS: 5-YEAR FOLLOW-UP STUDY
    Zaytseva, Yuliya
    Korsakova, Natalya K.
    Gurovich, Isaac Ya
    PSYCHIATRIA DANUBINA, 2010, 22 : S149 - S151
  • [5] PROGNOSIS IN SCHIZOPHRENIA - 5-YEAR FOLLOW-UP
    BURSTEIN, AG
    ADAMS, RL
    CHAPMAN, LJ
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1974, 159 (02) : 137 - 140
  • [6] Gray matter deficits are stable in first episode psychosis: A 5-year follow-up study
    Zipursky, RB
    Christensen, BK
    Dolman, RA
    Mikulis, DJ
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 170 - 171
  • [7] Progressive brain changes in patients with schizophrenia: A 5-year longitudinal MRI study across the course of illness
    van Haren, NE
    Pol, HEH
    Cahn, W
    Schnack, HG
    Brans, R
    Collins, DL
    Evans, AC
    Kahn, RS
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 408 - 409
  • [8] Brain volume changes in patients with schizophrenia: A 5-year longitudinal MRI study across the course of illness
    van Haren, NEM
    Pol, HEH
    Cahn, W
    Schnack, HG
    Brans, R
    Laponder, AJ
    Kahn, RS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S126 - S127
  • [9] Gray matter volume changes in first-episode schizophrenia: a one year follow-up study
    Cahn, W
    Pol, HEH
    Lems, E
    van Haren, N
    Schnack, HG
    van der Linden, JA
    Kahn, RS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S33 - S33
  • [10] Social functioning and the course of recent-onset schizophrenia. A 5-year follow-up study
    Lenior, ME
    Linszen, DH
    Dingemans, PM
    Schene, AH
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 328 - 329